Outlook Therapeutics, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
OTLK on Nasdaq
Location
111 S. Wood Avenue, Unit #100, Iselin, NJ

Insiders trading volume in the past year

Outlook Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Tenshi Healthcare Pte. Ltd. 10%+ Owner $26.1M Apr 21, 2022
Arun Pillai Director, 10%+ Owner $26.1M Feb 1, 2022
Ghiath M. Sukhtian Director, 10%+ Owner $23.3M Jan 17, 2025
Terry Dagnon Chief Operations Officer $741K Apr 20, 2023
Syntone Ventures LLC 10%+ Owner $716K Apr 15, 2024
Jeff Evanson Chief Commercial Officer $340K Mar 20, 2024
Lawrence Kenyon Chief Financial Officer, Director $33.8K +$28.4K +529% Sep 26, 2024
Yezan Munther Haddadin Director $2.12K Oct 1, 2024
C. Russell Trenary III CEO AND PRESIDENT, Director Mar 20, 2024
A. Haller Director Oct 1, 2024
Gerd Auffarth Director Oct 1, 2024
Faisal Ghiath Sukhtian Director Feb 4, 2025
Andong Huang Director Oct 1, 2024
Kurt J. Hilzinger Director Oct 1, 2024
Julian S. Gangolli Director Oct 1, 2024
Randy H. Thurman Director Oct 1, 2024

Recent Insider Transactions by Companies or Individuals for Outlook Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.